Kemnay Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Kemnay Advisory Services's RPRX Position: Q2 2026 in Review
Kemnay Advisory Services increased its Royalty Pharma (RPRX) stake by 5.8% in Q2 2026, buying an estimated $468 and bringing the position to 164 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1062.
Kemnay Advisory Services first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Kemnay Advisory Services held 164 shares of Royalty Pharma worth $9.2K as of Q2 2026.
- Kemnay Advisory Services bought 9 Royalty Pharma shares in Q2 2026, an estimated $468.
- Royalty Pharma made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #1062 holding.
- Kemnay Advisory Services first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
- 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.